Business Context and Reporting Period
Company: Primedex Health Systems, Inc. (Note: Metadata listed Radnet, Inc., but the filing is for Primedex Health Systems, Inc., which consolidates Radnet and Diagnostic Imaging Services, Inc.)
Reporting Period: Quarter and six months ended April 30, 2001.
Business: Provides diagnostic imaging services in California through subsidiaries Radnet and DIS.
Key Financial Metrics
| Metric | Six Months Ended Apr 30, 2001 | Six Months Ended Apr 30, 2000 |
|---|---|---|
| Net Revenue | $50,214,033 | $41,884,869 |
| Income from Operations | $9,194,635 | $6,197,205 |
| Net Income | $6,137,504 | $506,407 |
| Diluted EPS | $0.14 | $0.01 |
| Cash from Operating Activities | $5,756,208 | $3,487,917 |
| Cash and Equivalents (End of Period) | $46,374 | $43,254 |
| Working Capital Deficit | ($29,248,865) | ($44,587,808) |
| Stockholders' Deficit | ($54,645,247) | ($60,912,876) |
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased approximately 20% year-over-year, driven by five new sites opened in fiscal 2000 and a new capitation contract at the Riverside facility (HCIC) which increased net revenue by 126%.
- Profitability: Net income surged from $506,407 to $6,137,504. This was significantly aided by a one-time gain of approximately $3.53 million from the sale of the Valley Regional Oncology Center (VROC).
- Operating Expenses: Increased approximately 15% to $41.02 million. The increase was largely due to operating costs for the five new facilities ($2.9 million) and higher maintenance fees under a GE contract.
- Liquidity Improvement: The working capital deficit improved by $15.3 million, narrowing from $44.6 million to $29.2 million, primarily due to debt restructuring and asset sales.
Outlook, Risks, and Unusual Items
- Going Concern Warning: The filing explicitly states that the stockholders' deficit of $54.6 million and working capital deficit of $29.2 million raise "substantial doubt" about the company's ability to continue as a going concern.
- Unusual Items:
- Asset Sale: Sold VROC for $4 million cash, recognizing a $3.525 million gain.
- Debt Restructuring: Converted a $5.54 million note payable into non-voting convertible preferred stock. Renegotiated GE notes and settled historical notes via warrant exercises.
- Extraordinary Gains: Recorded $113,103 in gains from extinguishment of debt.
- Management Strategy: Plans to improve liquidity by selectively opening new centers, renegotiating managed care contracts, eliminating poor-performing contracts, and consolidating underperforming facilities.
- Subsequent Events: Acquired Modesto Imaging Center ($7.5 million) and equipment for two Palm Springs/Desert centers in May/June 2001.
Investor Verification Checklist
- Debt Covenants: Verify the terms of the two primary lines of credit (Coast Business Credit and DVI Business Credit) and the risk of default given the working capital deficit.
- Recurring Revenue: Assess the sustainability of the 126% revenue increase at the Riverside facility and the impact of the new capitation agreements.
- One-Time Gains: Confirm that the $3.5 million gain from the VROC sale is non-recurring and exclude it when evaluating core operating performance.
- Related Party Transactions: Review the $1.33 million in notes payable to related parties and the $475,000 in advances/loans to officers for potential conflicts or liquidity risks.
- Going Concern Status: Monitor the company's ability to meet the $44.5 million in scheduled debt and lease payments over the next five years.